For health care professionals only

The information contained on this website is intended for use only by health care professionals in the United States. Countries outside of the United States may have different regulatory requirements or medical practices than the United States. Therefore, this information may not be appropriate for use outside of the United States.

Are you a health care professional in the United States?

You will now be leaving the NovoSeven® RT website.

What is NovoSeven® RT?


NovoSeven® RT is the only recombinant Recombinant
Genetically engineered DNA. Made without human blood or plasma. Factor VII (7) Factor VII (7)
One of the 13 clotting-factor proteins that helps form blood clots. product available for the treatment of bleeding Bleeding
In hemophilia, a collection of blood in an area, such as a muscle or joint. episodes and prevention of surgical bleeding in patients with hemophilia A Hemophilia A
A bleeding disorder caused by lack of Factor VIII (8). It is sometimes called classic or standard hemophilia. or B Hemophilia B
A bleeding disorder caused by lack of Factor IX (9). with inhibitors Inhibitor
A substance made by the body that attacks factor so it cannot work as well. For example, a Factor VIII (8) inhibitor would keep Factor VIII from working with other factors and platelets to stop bleeding. to Factor VIII (8) Factor VIII (8)
One of the 13 clotting-factor proteins that helps form blood clots. or Factor IX (9) Factor IX (9)
One of the 13 clotting-factor proteins that helps form blood clots. , patients with acquired hemophilia Acquired hemophilia
A form of hemophilia in which the body starts producing antibodies that fight its own blood-clotting proteins. , and patients with congenital Factor VII deficiency Congenital Factor VII (7) deficiency
A bleeding disorder in which there are low levels of Factor VII in the blood..


How NovoSeven® RT works

There are 13 factors Factor
A protein in the blood that helps form blood clots. in the clotting Clotting
The process of forming into a clot or clots. process. Clotting happens when each factor works together in the right order. The clotting process can be slowed or stopped if 1 factor is blocked or missing. In order for a stable clot Clot
The thickened mass of blood and cells your body forms to stop the bleeding at the place where you have been injured. to form, the deficient Deficient
A lack or shortage of something. factor in the blood-clotting Blood clotting
Also known as coagulation. It is the process of turning some of the elements in the blood into a clot. Blood clotting is the result of a sequence of actions and reactions that involve several different proteins in the blood. process must be replaced or bypassed.

NovoSeven® RT is called a bypassing agent Bypassing agent
A product that treats a bleed without the need for Factor VIII (8) or Factor IX (9). because it skips the need for Factor VIII or IX in people with inhibitors, instead activating Factor X (10) directly. For people with Factor VII deficiency Factor VII (7) deficiency
A rare bleeding disorder in which the blood has low levels of Factor VII. Factor VII is important in the blood-clotting process because it binds to blood cells near the location of an injury and to activated platelets, setting the clotting process in motion., NovoSeven® RT is used to replace the missing factor, so the clotting process can continue.

NovoSeven® RT targets the site of injury, bypasses the inhibitor, and controls bleeds fast